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Original Article
A Zebrafish Live Imaging Model Reveals Differential
Responses of Microglia Toward Glioblastoma Cells In Vivo
Lloyd Hamilton, Katy R. Astell, Gergana Velikova, and Dirk Sieger
Abstract
Glioblastoma multiforme is the most common and deadliest form of brain cancer. Glioblastomas are infiltrated
by a high number of microglia, which promote tumor growth and surrounding tissue invasion. However, it is
unclear how microglia and glioma cells physically interact and if there are differences, depending on glioma
cell type. Hence, we have developed a novel live imaging assay to study microglia–glioma interactions in vivo
in the zebrafish brain. We transplanted well-established human glioblastoma cell lines, U87 and U251, into
transgenic zebrafish lines with labelled macrophages/microglia. Our confocal live imaging results show distinct
interactions between microglia and U87, as well as U251 glioblastoma cells that differ in number and nature.
Importantly these interactions do not appear to be antitumoral as zebrafish microglia do not engulf and phago-
cytose the human glioblastoma cells. Finally, xenotransplants into the irf8-/- zebrafish mutant that lacks microglia,
as well as pharmacological inhibition of the CSF-1 receptor (CSF-1R) on microglia, confirm a prominent role for
zebrafish microglia in promoting human glioblastoma cell growth. This new model will be an important tool for
drug screening and the development of future immunotherapeutics targeting microglia within glioma.
Keywords: microglia, glioma, brain tumor, macrophages
Introduction
Gliomas are the most common type of malignant braintumor. The most aggressive and frequently occurring
form of glioma is known as glioblastoma multiforme (GBM),
or high grade astrocytoma. GBM is incurable and has a me-
dian survival rate of less than 14 months.1,2 GBMs display
extensive intra- and intertumoral heterogeneity in both mor-
phological features and genetics.3,4 Furthermore, glioblasto-
mas show a diffuse appearance, which is the main reason why
these tumors cannot be cured by surgical resection. Although
Scherer described the migration of glioma cells away from the
main tumor mass as early as 1940,5 the underlying mecha-
nisms are still not understood. Recent studies suggest that high
levels of macrophages/microglia within the glioma are posi-
tively correlated with glioma grade and invasiveness.6–17
Microglia are the residential macrophages of the brain.18,19
Among many other functions, microglia sense injuries in the
brain immediately, migrate to the site of the lesion, and
phagocytose detrimental material.20–23 Strikingly, a compa-
rable course of events is observed during glioma progression
in the brain, where microglia and infiltrating macrophages are
attracted to and colonize the tumor.6,7,9,16,17 However, in-
stead of antitumoral activity they display protumoral func-
tions and promote tumor growth.11–15,24–27 Microglia/
macrophages within glioblastomas have been found to
account for 30% of the gliomamass and have been implicated
in establishing an immunosuppressivemicroenvironment.6,7,16
Thus, understanding the nature of microglia–glioma inter-
actions in vivo could be the first step to develop future al-
ternative strategies to interfere with glioma growth and
invasiveness.
The zebrafish represents a powerful model system to ex-
plore cellular responses and molecular events in vivo. It has
been established as a model to study various types of human
cancer, ranging from B-Cell/T-Cell leukemia and melanoma
to glioma.28–38 We have utilized a zebrafish xenotrans-
plantation live imaging model to address microglia–glioma
interactions. The zebrafish larva provides optimal charac-
teristics that are advantageous for these studies. First, the
zebrafish immune system is unique in the sense that after
fertilization, the larvae survive only with the innate immune
system.39,40 Maturation of the immune system leading to the
development of the adaptive immune response occurs at
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between 3 and 6 weeks postfertilization.39,40 Thus upon xe-
nograft these early events during tumor colonization can be
studied in detail without interference by the highly diversi-
fied and complex response of an adaptive immune system.
Second, a major benefit of the larval model is the optical
transparency, which makes it possible to directly observe and
classify the different microglia–glioma interactions in vivo in
high resolution. To perform similar studies in a rodent model
the insertion of a cranial window is necessary.41 While fea-
sible, this requires an additional surgical procedure that needs
to be tolerated by the animal. Furthermore, immunosup-
pression has to be applied upon transplantation of human
cells, which might impact microglia–glioma interactions as
well. To overcome this limitation, orthotopic syngeneic
mouse models like the GL261 glioma model have been
developed.42 This model, in combination with two-photon
imaging, has been used very recently to monitor how mi-
croglia respond tomouse GL261 glioma cells.43–45 However,
interactions of microglia with human glioblastoma cells have
never been visualized to date.
We have exploited recently established zebrafish lines with
fluorescently labelledmacrophages/microglia to simultaneously
monitor the migration and movement of microglia and glio-
blastoma cells, as well as their interactions with each other.
Transplantation of human U87 and U251 glioblastoma cells
into the zebrafish brain led to an immediate microglial re-
sponse. To test if these responses were specific for glioblas-
toma cells, we performed heterotopic transplants of human
fibrosarcoma cells (HT1080). Interestingly, we observed spe-
cific nonphagocytic interactions with U87 and U251 cells,
which were different in number and in nature. Importantly,
microglial responses toward HT1080 cells were very different
and many of these cells were immediately engulfed. Finally,
xenotransplants into the irf8-/- zebrafish mutant, which lacks
microglia, confirmed a prominent role for microglia in pro-
moting U87 and U251 tumor cell survival. In summary, our
results show that the zebrafish larva is a powerful tool to study
specific interactions between microglia and glioma cells.
Materials and Methods
Cell culture
Human U87MG glioblastoma cells were kindly provided
by Prof Tobias Pukrop (University Hospital Regensburg,
Germany). Human U251MG glioblastoma cells were pur-
chased from CLS Cell Lines Service (Eppelheim, Germany),
and human HT1080 cells were kindly provided by Dr Pamela
Brown (SURF, University of Edinburgh). U87MG cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
containing 1% l-glutamine and supplemented with 1% (v/v)
Penicillin/Streptomycin (100mg/mL penicillin and 100mg/
mL streptomycin) and 10% (v/v) fetal calf serum at standard
conditions of 100% humidity and 5%CO2, at 37C. U251MG
cells were cultured in DMEM containing 1% l-glutamine and
supplemented with 1% (v/v) Penicillin/Streptomycin, 0.1mM
nonessential aminoacids, 1mMsodiumpyruvate, and10%(v/v)
fetal calf serumat standard conditions of 100%humidity and5%
CO2, at 37C.HT1080 cells were cultured inDMEMcontaining
30mg/L GlutaMAX, 4.5 g/L d-Glucose, and 2.5mM HEPES
supplemented with 1% (v/v) Penicillin/Streptomycin and 10%
(v/v) fetal calf serum at standard conditions of 100% humid-
ity and 5% CO2, at 37C. Cells were harvested on the day of
the xenograft transplantation. The cells were washed with
phosphate-buffered saline (PBS) and detached from the surface
of the flask by incubation in 2mM EDTA in PBS for 15min at
34C. The EDTA was removed with a 10mL DMEM wash
followed by a 10mL PBS wash; cells were centrifuged for
1.5min at 0.2 g between washes. The resulting cell pellet was
resuspended in 100lL DMEM, supplemented with phenol red
(1:10 v/v), to a final concentration of 5· 107 cells/mL in prep-
aration for the xenografts.
Lentiviral transductions and CM-DiI dye labelling
For lentiviral transductions, cells (4.5· 105) were seeded
into 60mm dishes in a final volume of 5mL DMEM. Cells
were allowed to adhere to the dish for 4 h, at standard incubator
conditions. HT1080 cells were grown on Matrigel to allow
transformation. Polybrene (5 ng/mL) was added directly to the
culture medium and incubated for 10min at 37C. The Lv-
cppt-IRES-mCherry-opre viral vector (Dr. P. Brown, SURF)
at a multiplicity of infection of 10 was then added to the ex-
istingmedia and was incubated at standard conditions for 48 h.
After 48 h, the media containing viral vector were removed.
The transformed cells were detached from the culture dish by
15min of 2mM EDTA-PBS treatment at 37C and given a
10mL DMEM wash and then 10mL PBS wash; cells were
centrifuged for 1.5min at 0.2 g between washes. The resulting
cell pellet was resuspended in 10mL DMEM and seeded into
cell culture dishes at the required density. This procedure gave
rise to cell lines that stably expressed the mCherry reporter
protein, which was evenly distributed throughout the cells.
These mCherry expressing cells are referred to as U87, U251,
and HT1080 cells throughout the text.
CM-DiI Dye (Molecular Probes) was dissolved in DMSO
according to manufacturer’s instructions, and a working
concentration of 2 lM was used for cell labeling. Cells were
incubated in 2 lM CM-DiI Dye for 10min at 4C. This was
followed by two PBS washes and a media replacement in
preparation for harvesting.
Mammalian cell growth kinetics
The growth rates of HT1080 mCherry, U87 mCherry, and
U251 mCherry cells at 34C compared to 37C were deter-
mined over a 4-day period. Monolayer cultures of each cell
line were harvested, using Accutase (Sigma-Aldrich), when
*75% confluent. The detached cells were washed once with
1 · PBS and resuspended in culture medium. The cells were
counted using a Neubauer counting chamber (depth 0.1mm,
1/400mm2; Hawksley), and 1500 cells, in 1mL, of culture
medium were transferred into the wells of 12-well plates.
Cells were cultured continuously for up to 4 days, without
replenishing media, at either 34C or 37C under normoxic
conditions. Each day (at 24-h intervals), the cell number, in
three individual wells, was counted for each cell line and the
average cell number was calculated. The experiment was
repeated in triplicate, and the average cell numbers, from the
three experiments, were plotted to produce growth curves.
Zebrafish maintenance, xenografts,
and pharmacological treatments
Zebrafish were housed in a purpose built zebrafish facility,
in the Queen’s Medical Research Institute, maintained by the
University of Edinburgh Biological Resources. All zebrafish
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larvae were kept at 28C on a 14-h light/10-h dark photo-
period. Embryos were obtained by natural spawning from
adult mpeg1:EGFP46 and irf8-/-47 zebrafish strains. Animal
experimentation was approved by the Ethics Review Com-
mittee of the University of Edinburgh and the Home Office,
in accordance with the Scientific Procedure Act 1986. Em-
bryos were treated with 200lM 1-phenyl 2-thiourea (PTU)
from the end of the first day of development for the duration
of the experiment to inhibit pigmentation. Xenografts were
conducted on larvae that had been dechorionated and an-
esthetized with 2.5mM Ethyl 3-aminobenzoate methane-
sulfonate (Tricaine) in zebrafish embryonic medium (6.4mM
KCl, 0.22mM NaCl, 0.33mM CaCl2 2H2O, 0.33mM
MgSO4 7H2O), at 3 dpf. Anesthetized zebrafish larvae were
immobilized in 1.5% (w/v) low-melting point agarose solu-
tion made with zebrafish embryonic medium. The heads of
the embryos were carefully exposed from the agarose before
transplantation (Fig. 1). All transplantations were performed
using a FemtoJet 4i microinjector (Eppendorf, Hamburg,
Germany). Transplantation needles were prepared from bo-
rosilicate glass capillaries, lacking an internal filament, using
a glass micropipette puller (Sutter Instrument Co. P-87, No-
vato). U87/U251/HT1080 cells (n= 8–30) were transplanted
into the optic tectum of each zebrafish larva. Individual zeb-
rafish larvae containing U87/U251/HT1080 cells were main-
tained in 12-well plates, containing 4mL zebrafish embryo
medium supplemented with 200lM PTU, at 34C. For phar-
macological treatments, U87 cell transplanted larvae were
maintained in 24-well plates in zebrafish embryo medium
supplemented with 200lMPTU, at 34C. Transplanted larvae
were treated from 4 dpf (1 day posttransplantation) with either
1%DMSO (control) or 1%DMSO/25lMBLZ945 for 5 days.
Larvae were imaged at 4 dpf before the start of treatment to
obtain microglial cell counts and U87 cell counts. Treated
larvae were kept individually and imaged at the end of treat-
ment (9 dpf) to obtain final microglia and U87 cell counts.
Imaging
Zebrafish larvae were anesthetized with 2.5mM tricaine in
embryonic medium and mounted in 1.5% (w/v) low-melting
point agarose. Time lapse and still images were obtained
using an Andor spinning disk confocal fluorescent micro-
scope with a 20 · /NA 0.75 Olympus objective lens. The
acquired z stacks for both single time point and time lapse
images were selected to encompass all regions of interest
within the zebrafish larval brain. Time lapse imaging was
conducted for a period of 14–17 h with the time interval be-
tween images set at 3min. Single time point images were
obtained at 0–4 days posttransplantation (dpt).
Analysis
Analysis of all images was conducted using Imaris (Bitplane,
Belfast, United Kingdom). All data were plotted using Graph-
Pad and analyzed using onewayANOVA and post hoc analysis
with Sidak’s multiple comparisons test. The cell number was
determined for each image by manual counting in 3D. These
values were used to plot survival curves for each cell type in the
different zebrafish lines. The survival curve was determined as
the ratio expressed as a percentage between the cell number at
each time point and the starting cell number.
The number of microglia interactions between individual
microglia and the transplanted cells was measured by counting
the number of direct interactions between both cell types and
normalizing for the number of xenografted cells at the re-
spective time point. Interactionswere defined as direct contacts
between microglial surfaces and transplanted cell surfaces,
including engulfment and phagocytosis of transplanted cells
(Supplementary Fig. S1B–E; SupplementaryData are available
online atwww.liebertpub.com/zeb). If amicroglial cell showed
several protrusions in contact with a single transplanted cell,
this was counted as one interaction between these two cells.
The invasiveness of the different cell types was determined
by measuring the spread of fluorescently labelled cells in 3D
within the zebrafish larval brain over time. Using Imaris, a 3D
sphere was created to encompass all fluorescent cells of in-
terest. Transplanted cells that had been engulfed by macro-
phages/microglia were not included within the sphere (see
Results section; Supplementary Fig. S2C¢, D¢). The diameter
of the created 3D sphere was used to measure invasiveness.
Invasiveness was determined as a percentage between the
FIG. 1. Zebrafish larval xe-
nograft. (A–A2) Schematic
representation of the xenograft
technique, lateral view. (A)
Zebrafish larvae were moun-
ted in low-melting point aga-
rose (beige). (A1)Larval heads
were released from the low-
melting point agarose to allow
cell transplantation into the
brain. (A2) Cells (red) were
transplanted into the optic
tectum. (B–B3) Schematic
representation of the xenograft
technique, dorsal view. Cells
(red) were transplanted into
the left optic tectum, stimu-
lating a microglia (green) re-
sponse (depending on cell
type). The right optic tectum
served as an internal control.
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final diameter of the sphere, required to encompass the trans-
planted cells 4 dpt compared to the diameter of the sphere
surrounding the initial cell mass directly after transplantation.
Results
In vivo imaging reveals different growth patterns
and microglial responses for U87 and U251
glioblastoma cells in the larval zebrafish brain
The combination of fluorescent transgenic tools and the
innate optical transparency of the zebrafish larva makes it
possible to study microglial interactions under high temporal
and optical resolution in the living brain.23,48–50 To study
microglial responses to xenografted human glioblastoma cells,
we made use of the mpeg1:EGFP transgenic zebrafish, in
which all macrophages, including microglia, can be visualized
and tracked.46 The xenotransplantation protocol used in this
study is an optimized version of our previously developed
injection protocol and is minimally invasive.23 Briefly, larvae
were mounted in low-melting point agarose, and their heads
were carefully exposed from the agarose using a sharp needle
before transplantation (Fig. 1A–A2). Transplantations were
performed into the left optic tectum using a glass capillary
(Fig. 1B–B3). Sham injections of culture media led only to a
short injury response of microglial cells that were in direct
proximity to the injection site. This injury response was usu-
ally resolved within a few hours (data not shown). To study
microglial responses to glioblastoma cells, we transplanted
human-derived U87mCherry (referred to as U87) and
U251mCherry (referred to as U251) glioblastoma cells into the
optic tectum and whole brain confocal imaging was performed
at 0–4 dpt. To test if microglial responses were specific for
glioblastoma cells, we performed heterotopic transplants of the
human fibrosarcoma cell line HT1080mCherry (referred to as
HT1080) and performed imaging at the same time points.
Upon transplantation of U87 and U251 glioblastoma cells
into the larval zebrafish tectum, the cells invaded the sur-
rounding tissue of the optic tectum moving away from the
initial transplantation site (Fig. 2). However, it was immedi-
ately obvious that U251 cells and U87 cells had very different
cellular morphologies within the zebrafish brain (Fig. 2). U251
glioblastoma cells showed infiltrative cellular protrusions that
projected from the main cell bodies into the surrounding tissue
(Fig. 2B¢, C¢, arrows). In most U251 samples, it was observed
that these projections extended to over 100lm in length and
formed interactions with microglia outside of the central gli-
oma mass (Fig. 2C¢, arrows, arrowheads). Furthermore, U251
cells attractedmanymicroglia that stayedwithin the vicinity of
theU251 cells over the duration of the experiment (Fig. 2A–C).
These microglia showed different types of interactions with
U251 cells (see below) that could be observed over the full
duration of the experiment (Fig. 2A¢–C¢, arrowheads).
Transplanted U87 cells showed a different morphology
compared to U251 cells (Fig. 2D–F). The borders of the main
U87 glioblastoma cell mass were more defined, and cellular
protrusions were observed to a much lesser degree compared
to the U251 cells (compare Fig. 2C¢, arrows to Fig. 2F¢, ar-
rows). Nevertheless, single-invasive U87 cells were observed
outside the main cell mass (Fig. 2E¢, F¢). U87 cells also at-
tracted microglia and interactions between the U87 cells and
microglia (see below) were observed at all time points
(Fig. 2D¢–F¢, white arrow heads).
Interestingly, heterotopic transplants of human HT1080
cells into the larval zebrafish brain resulted in a different out-
come. HT1080 cells attracted many microglia (Fig. 2G¢) and
these microglia immediately engulfed HT1080 cells (Fig. 2H¢,
I¢ and Supplementary Fig. S1B). Thus after 4 dpt, many
HT1080 cells were detected within phagosomes of microglia,
while less than half of theHT1080 cells escaped engulfment by
microglia (Fig. 2I¢ and Supplementary Fig. S1B).
Microglia differently interact with U87 and U251 cells
To analyze the nature of interactions between microglia and
the different transplanted cell types in more detail, we per-
formed live imaging of U87, U251, and HT1080 transplanted
mpeg1:EGFP fish at 3-min intervals for up to 14h. These time
series revealed obvious differences in the responses of mi-
croglia toward the different cell types. Interestingly, microglia
behavior was very different upon transplantation of U87 and
U251 cells. U251 cells immediately attracted many microglia
(Fig. 3A and Supplementary Movie S1). These microglia
deeply infiltrated the U251 cell mass and exhibited continuous
interactions over the remaining hours (Fig. 3A and Supple-
mentary Movie S1). We observed two main types of cellular
surface interactions. The first type of interaction observed was
a long-lasting interaction between individual microglia and
single U251 cells (Fig. 3A3–A6 [arrowhead] and Supplemen-
tary Movie S1). Here microglia flatten their surfaces against
the surface of the U251 cells and keep this close position for
hours while slightly moving on the surface of the U251 cells
(Fig. 3A3–A6 [arrowhead] and SupplementaryMovie S1). The
second type of interaction observed was of dynamic nature,
reflected in constant extensions and retractions of microglial
processes that made contact with the surface of U251 cells
(Fig. 3A7–A10 [asterisk, arrows] and Supplementary Movie
S1). These contacts were of short duration (minutes) and in-
dividual microglia interacted with several U251 cells. In
comparison to U251 cells, U87 cells attracted a lower number
of microglial cells and they did not penetrate the U87 cellular
mass (Fig. 3B and Supplementary Movie S2). Despite this
difference, we detected interactions between the microglia and
transplanted U87 cells. Microglia remained at the margin of
the U87 cell mass and sent out and retracted cellular protru-
sions to make contact with the U87 cells (Fig. 3B3–B6 [as-
terisks, arrows]). As observed for U251 cells, these contacts
were of short duration and individual microglia interacted with
several U87 cells (Supplementary Movie S2).
As stated before, the microglial response toward HT1080
cells was very different. Following transplantation of
HT1080 cells into the larval zebrafish brain, the main mi-
croglial response resulted in the immediate engulfment of
many of these cells (Fig. 3C and Supplementary Movie S3).
Over the time course, several microglia cells were found to
contain HT1080 cellular fragments within their phagosomes
(Fig. 3C3–C6 [arrowheads] and Supplementary Fig. S1B–
SB4). This explains the decrease in HT1080 cell numbers that
we observed over the 4-day time course (Fig. 4A).
U87 and U251 glioma cells show differences
in growth and number of microglia interactions
in the larval zebrafish brain
To investigate the growth of the different cell types upon
transplantation, we performed cell counts based on the confocal
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FIG. 2. U251, U87, and HT1080 cells exhibit different growth patterns in the zebrafish optic tectum and stimulate an
intensive microglia response. Representative confocal images of the optic tectum of mpeg1:EGFP zebrafish transplanted with
U251mCherry (U251) glioblastoma cells, U87mCherry (U87) glioblastoma cells, and HT1080mCherry (HT1080) fibrosar-
coma cells at 3 dpf. (A–C) Images from top to bottom are in chronological order showing 0, 2, and 4 dpt of U251 cells; (A¢–C¢)
Higher magnification of regions of interest in (A–C) to highlight interactions of microglia (green) and U251 cells (red). U251
cellular projections are marked with a white arrow. Microglia interacting with U251 cells are marked with a white arrowhead.
(D–F) Images from top to bottom are in chronological order showing 0, 2, and 4 dpt of U87 cells; (D¢–F¢) Higher magni-
fication of regions of interest in (D–F) to highlight interactions of microglia (green) and U87 cells (red). U87 cellular
projections are marked with a white arrow. Microglia interacting with U87 cells are marked with a white arrowhead. (G–I)
Images from top to bottom are in chronological order showing 0, 2, and 4 dpt of HT1080 cells; (G¢–I¢) Higher magnification of
regions of interest (G–I) to highlight interactions of microglia (green) and HT1080 cells (red). Microglia interacting with
HT1080 cells are marked with a white arrowhead. Scale bars for (A–I): 50lm. Scale bars for (A¢–I¢): 30lm. All images
represent maximum intensity projections of confocal stacks. Images were captured using an Andor spinning disk confocal
microscope with a 20· /NA 0.75 objective. Insets in (A, G, and D) show the orientation of samples (anterior to the top) and
the region imaged (white rectangle). dpf, days postfertilization; dpt, days posttransplantation
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z-stacks acquired at the different time points. These results show
that U87 survival was significantly higher at all time points
compared to both U251 and HT1080 (Fig. 4A). Over the course
of the experiment, U87 cell numbers increased to 180%–
35.1%, while U251 cell numbers remained constant (Fig. 4A).
The observed difference in growth for U87 cells and U251 cells
upon transplantation is in line with their in vitro growth rates.
The comparison of growth rates for these cells at 37C and 34C
in vitro showed that U87 cells growmuch faster than U251 cells
at both 37C and 34C (Supplementary Fig. S1A). In compari-
son,HT1080 cell numbers decreased to 47.6%– 4.8%at 4 dpt in
the zebrafish larval tectum (Fig. 4A). This is in contrast to their
FIG. 3. Microglia interact differently with
U251, U87, and HT1080 cells. (A) Confocal
time series showing microglia (green) re-
sponding to U251 cells (red) in the zebrafish
optic tectum (recording times indicated; see
also Supplementary Movie S1). (A3–A6)
Time series highlighting a microglial cell
closely interacting with a U251 cell for more
than 60min. White arrowhead marks the
microglial cell interacting with the U251 cell.
(A7–A10) Time series highlighting a micro-
glial cell constantly sending and retracting
processes toward U251 cells. White asterisk
marks a microglial cell sending and retracting
processes. White arrows mark microglial
processes toward U251 cells. Scale bars for
(A–A2): 30lm. Scale bars for (A3–A10):
15lm. (B) Confocal time series showing
microglia (green) responding to U87 cells
(red) in the zebrafish optic tectum (recording
times indicated; see also Supplementary
Movie S2). (B3–B6) Time series highlighting
a microglial cell closely interacting with U87
cells. White asterisk marks a microglial cell
sending and retracting processes. White ar-
rows mark microglial processes toward U87
cells. Scale bars for (B–B2): 30lm. Scale
bars for (B3–B6): 20lm. (C) Confocal time
series showing microglia (green) responding
to HT1080 cells (red) in the zebrafish optic
tectum (recording times indicated; see also
Supplementary Movie S3). (C3–C6) Time
series highlighting microglia engulfing and
phagocytosing HT1080 cells. Arrowheads
indicate microglia engulfing and phagocy-
tosing HT1080 cells. Scale bars for (C–C6):
30lm. All images represent maximum in-
tensity projections of confocal stacks. Images
were captured using an Andor spinning disk
confocal microscope with a 20· /NA 0.75
objective.
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growth in vitro as HT1080 cells were observed to grow faster
than U251 cells at 37C and 34C (Supplementary Fig. S1A).
Thus, orthotopic transplants ofU87 andU251glioblastoma cells
into the optic tectum of the zebrafish brain show a greater rate of
survival compared to heterotopic HT1080 transplants.
Although glioma infiltration by microglia has been de-
scribed in many studies, interactions between microglial cells
and the glioma cells have only been described recently in vivo
for a mouse GL261 glioma model.43–45 Microglial interac-
tions with human glioblastoma cells have never been directly
visualized in vivo at high resolution until now. To ascertain if
the different transplanted human glioma cell types stimulate a
different number of microglia interactions, the number of
individual microglia cells in direct contact with transplanted
cells was analyzed based on the confocal stacks acquired
between 0 and 4 dpt (see Materials and Methods section and
Fig. S1C, E).
U251 glioblastoma cells stimulated a significantly higher
number of microglia interactions compared to U87 (Fig. 4B,
C). One way ANOVA of the total number of microglial in-
teractions over the whole 4-day period indicated a signifi-
cant difference in the number of microglial interactions with
U251 cells (2.61– 0.150, n = 15) compared to U87 cells
(1.73– 0.264, p = 0.037, n = 8) (Fig. 4C). HT1080 cells
stimulated a high number of microglial interactions (3.31 –
0.338, n = 10; Fig. 4B, C) compared to U87 (1.73– 0.264,
p = 0.0005, n = 8). However, microglia-HT1080 cell interac-
tions were very different in nature compared to interactions
with U87 and U251 cells and included a high degree of en-
gulfment of HT1080 cells.
We have shown that transplanted U87, U251, and HT1080
cells differ in survival rates and microglial responses. To test
if these cell types show differences in their infiltrative be-
havior, we measured their invasiveness in 3D over time. This
was achieved by creating a 3D sphere that accurately en-
compassed the transplanted cells at the different time points
(see Materials and Methods section and Supplementary
Fig. S2D). The diameter of the created 3D sphere was used
FIG. 4. Growth and invasiveness of U87, U251, and HT1080 cells are accompanied by a different number of microglial
interactions. U87, U251, and HT1080 cells were transplanted into the larval zebrafish tectum at 3 dpf, and larvae were
imaged at 0–4 dpt. 3D images were analyzed using Imaris (see Materials and Methods section). (A) Survival of U87, U251,
and HT1080 cells over 4 days displayed as the ratio (expressed as a percentage) between the cell number at each time point
and the starting cell number. p Values for the different time points are: 1 dpt U87 versus U251, p = 0.0454; U87 versus
HT1080, p = 0.0002; U251 versus HT1080, p = 0.0366; 2 dpt U87 versus U251, p = 0.0044; U87 versus HT1080, p < 0.0001;
U251 versus HT1080, p= 0.1352; 3 dpt U87 versus U251, p = 0.0003; U87 versus HT1080, p < 0.0001; U251 versus
HT1080, p = 0.0008; 4 dpt U87 versus U251, p= 0.0111; U87 versus HT1080, p = 0.0419; and U251 versus HT1080,
p = 0.0419. (B) Average number of microglial interactions per transplanted cell from day 0 to day 4 posttransplantation for
U87, U251, and HT1080 cells. (C)Mean of the total number of microglial interactions for U87, U251, and HT1080 cells per
transplanted cell in mpeg1:EGFP zebrafish over 4 days. (D) Mean of cell invasiveness in percent. n numbers represent the
number of larvae. All error bars represent the standard error of the mean. p values are indicated on graph.
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to measure invasiveness. By calculating the fold increase be-
tween spheres on sequential days, a valuation of invasiveness
could be obtained. Based on this method, we compared the
invasiveness of the different cell types. Interestingly, although
U87 cells showed the best rate of survival in our experiments
(Fig. 4A), U251 cells were the most invasive cells. U251 cells
showed the highest rate of surrounding tissue infiltration
(206.7%– 11.2%, n= 15) compared to HT1080 cells
(138.8%– 16.5%, p= 0.0107, n= 10) and U87 cells (165.9%–
15.7%, p= 0.203, n= 8) (Fig. 4D). Importantly, the results
observed in this study coincidewith previous histopathological
studies conducted in rodent models, which documented the
differences in invasiveness between the two glioblastoma
cell lines.51–53
Of note in this study, and of importance to measure inva-
siveness accurately, these measurements have to be done in
3D, as 2D projections of confocal stacks do not reflect the
total invasiveness in all dimensions. Furthermore, cells need
to be stably expressing the fluorophore as trials using dye
labelled cells (CM-DiI Dye) showed false positive rates of
invasiveness due to detection of small fluorescent particles
that may be either pure dye aggregates or vesicles released by
tumor cells (Supplementary Fig. S2A, B). These small dye
aggregates spread within the tissue in all dimensions, thus,
including these particles leads to misleading results and an
overestimation of invasiveness. Furthermore, an important
prerequisite to measure invasiveness precisely is an addi-
tional labelling for microglia. Depending on the cell type,
transplanted cells might be engulfed by microglia and signals
will be detected within microglial phagosomes. These signals
do not represent viable cells, and thus, do not reflect true
infiltration. Only the additional microglial labelling allows
the identification of these engulfed cells to exclude them from
the analysis (Supplementary Fig. S2C, D).
Microglia promote U87 and U251 cell growth
To further investigate the direct role of microglia–glioma
interactions in promoting survival, proliferation, and inva-
siveness of glioma cells, xenografting experiments were con-
ducted in irf8-/- zebrafish that lack macrophages/microglia.
Interferon regulatory factor 8 (irf8) is vital for macrophage
development in mammals and in teleosts.47 The irf8 null
mutant (irf8-/-) zebrafish was characterized to lack macro-
phages up to around 7 dpf and microglia were absent in the
brain until 31 dpf.47 Thus we investigated xenografted U87,
U251, and HT1080 cell survival and invasiveness in irf8-/-
mutant zebrafish and compared the results to those observed in
our mpeg1:EGFP xenograft studies.
Xenografts in irf8-/- zebrafish highlighted a strong impact
of microglia on tumor progression for U87 cells and U251
cells. The results showed a significant reduction of U87 cell
survival at all time points in irf8-/- mutants compared to
mpeg1:EGFP (Fig. 5A). At 4 dpt the survival of U87 cells was
132%– 16% ( p< 0.0001) lower in irf8-/-mutants compared to
mpeg1:EGFP (Fig. 5A). In line with this, we detected a sig-
nificant decrease in tissue infiltration for U87 cells in irf8-/-
zebrafish (96.9%– 10.2%) versus mpeg1:EGFP (165.9%–
15.7%) (Fig. 5D). The survival of U251 cells in irf8-/- zeb-
rafish larvae was also significantly reduced (Fig. 5B). At 4 dpt
the survival of U251 cells was 41.4%– 11.62% ( p= 0.002)
lower in irf8-/- mutants compared to mpeg1:EGFP (Fig. 5B).
However, U251 tissue infiltration was not affected in irf8-/-
zebrafish (195.5%– 19.8%) compared to mpeg1:EGFP
(206.7%– 15.0%) (Fig. 5D).
Transplantation of HT1080 cells into irf8-/- zebrafish
showed contrasting results. While HT1080 survival was ra-
ther poor in mpeg1:EGFP fish, a trend was detected toward
better survival in the microglia mutant background (Fig. 5C).
The results showed a nonsignificant increase of HT1080 cell
survival by 27.1% – 12.1% ( p = 0.333) at 4 dpt in irf8-/-
mutants compared to mpeg1:EGFP (Fig. 5C). Although
better survival of HT1080 cells was observed in irf8-/- zeb-
rafish, we did not detect an increase in tissue infiltration for
HT1080 in the microglia mutant background (Fig. 5D).
To test if the protumoral function of the microglia can also
be altered by pharmacological means in our xenograft model,
we used the CSF-1R inhibitor BLZ945. CSF-1R signaling is
crucial for survival of macrophages and microglia. BLZ945
has recently been shown to target microglia in a mouse pro-
neural GBM model, leading to a regression of established tu-
mors.26 To test BLZ945 in our model, we transplanted
mpeg1:EGFP larvae with U87 cells at 3 dpf and incubated
these larvae from 4 dpf (1 dpt) in 25lM BLZ945 for 5 days.
These larvae developed normally and did not showany adverse
effects, confirming the high specificity for BLZ945 for the
CSF-1R. Indeed, treatment with BLZ945 led to reduction of
totalmicroglial numbers in the optic tectumand to a decrease in
U87 cell growth compared to controls (Fig. 6). Interestingly, as
BLZ945 treatment did not lead to an ablation of all microglia,
the impact on U87 cell growth was not as strong as observed
before in the irf8-/- zebrafish (compare Figs. 5A and 6).
Together, these results clearly show that zebrafish micro-
glia support the growth of human glioblastoma cells and,
thus, further highlight the suitability of the zebrafish model to
study human glioblastomas.
Discussion
The zebrafish as a model to study microglial
responses toward glioma cells
The xenografting live-imaging assay used in this study
presents a novel system that allows the response of the entire
microglial network during glioma colonization to be studied
in the living brain. Previous research has already demon-
strated the power of the zebrafish model to study glioma
growth. Several studies have transplanted glioma cells into
the zebrafish yolk and shown that these cells form tumors,
induce angiogenesis, and are responsive to treatment.54–56
Furthermore, intracranial models of glioma in larval zebra-
fish have been developed to study glioma invasiveness and
angiogenesis37 and to use the zebrafish as a powerful model
for drug screening.38,57 However, none of these studies have
investigated the microglial response to xenografted cells.
Thus we have established a larval zebrafish model to study
microglia–glioma interactions in real time in the living brain.
We show that transplantation of U87, U251, and HT1080
cells into the optic tectum of larval zebrafish stimulated a mi-
croglia response that resulted in the recruitment of microglia
cell bodies to the site of transplantation. The injection itself is
minimally invasive, andmedia onlywith sham injections show
a short injury response bymicroglial cells in direct proximity to
the injection site. This microglial response is usually resolved
within a few hours. However, the interactions observed upon
8 HAMILTON ET AL.
FIG. 5. Zebrafish microglia promote survival of U87 and U251 cells. U87, U251, and HT1080 cells were transplanted into
the larval zebrafish tectum of mpeg1:EGFP and irf8-/- zebrafish at 3 dpf and larvae were imaged at 0–4 dpt. (A) Com-
parison of survival for U87 cells in mpeg1:EGFP and irf8-/- zebrafish over 4 days displayed as the ratio (expressed as a
percentage) between the cell number at each time point and the starting cell number. (B) Comparison of survival for U251
cells in mpeg1:EGFP and irf8-/- zebrafish over 4 days displayed in as the ratio (expressed as a percentage) between the cell
number at each time point and the starting cell number. (C) Comparison of survival for HT1080 cells in mpeg1:EGFP and
irf8-/- zebrafish over 4 days displayed as the ratio (expressed as a percentage) between the cell number at each time point
and the starting cell number. (D) Comparison of the mean of cell invasiveness in mpeg1:EGFP and irf8-/- zebrafish. n
numbers represent the number of fish. All error bars represent the standard error of the mean. p values are indicated on graph
(ns = nonsignificant).
FIG. 6. Inhibition of CSF-1R signaling leads to reduced microglia numbers and impairs U87 cell growth. U87 cells were
transplanted into the larval zebrafish tectum of mpeg1:EGFP zebrafish at 3 dpf. Transplanted larvae were treated with 1%
DMSO or 1% DMSO/25lM BLZ945 from 4 dpf for 5 days. Microglial cell counts and U87 cell counts were done at 4 dpf
before the start of treatment and the end of treatment (9 dpf). (A) Comparison of microglial cell numbers in control (1%
DMSO) and BLZ945-treated zebrafish. Microglia numbers are displayed as the ratio (expressed as a percentage) of the final
numbers at 9 dpf divided by the starting number at 4 dpf. (B) Comparison of U87 cell numbers in control (1% DMSO) and
BLZ945-treated zebrafish. U87 cell numbers are displayed as the ratio (expressed as a percentage) of the final numbers at 9 dpf
divided by the starting number at 4 dpf. All error bars represent the standard error of the mean. p values are indicated on graph.
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xenotransplant lasted throughout the 4 days of imaging and
were intimate. We observed that microglial cell bodies, re-
siding outside of the transplantation site, extended projections
that interactedwith the glioma and fibrosarcoma cell surfaces.
Furthermore, our assay clearly stresses the importance of
orthotopic transplants, as microglial responses toward het-
erotopic transplants were very different. Importantly, mi-
croglia were observed to engulf many of the HT1080 cells
immediately, which is in line with the low survival rates we
observed for HT1080 cells. This indicates that HT1080 cells
trigger different signaling cascades leading to an increase in
microglial phagocytosis. Indeed, HT1080 cells show a very
different gene expression profile compared to U87 and U251
cells (Genevestigator58 differential gene expression com-
parison, not shown). Among the many differently regulated
genes, several genes coding for cytokines and cell surface
proteins can be found, including the lymphotoxin b receptor
(LTbR), for example. LTbR shows higher expression levels in
HT1080 cells compared to U87 and U251 cells. The activation
of LTbR has been shown to induce IL-8 expression and release,
leading to a pro-inflammatory environment and the attraction
of phagocytes.59 Furthermore, HT1080 cells show higher ex-
pression levels of IL-1a compared to U87 and U251 cells. IL-
1a has been reported to induce expression of IL-6, IL-8,
monocyte chemotactic protein-1, and granulocyte macrophage
colony-stimulating factor expression and, thus, to trigger in-
flammation.60 These signals and others might lead to a pro-
inflammatory activation of the microglia and to an increase in
their phagocytic activity.
Interestingly, for U87 and U251 glioma cells, we observed
distinct interactions with the microglia. U251 cells stimulated
a higher number of microglial interactions compared to U87
cells. Microglia infiltrated the U251 cell mass and intimately
interacted with U251 cells over the full duration of the ex-
periment. Furthermore, in U251 samples, microglia were often
seen to interact with U251 protrusions in the deeper tissue
outside of the glioma central mass. In comparison, U87 cells
attracted fewer microglia and these microglia showed only
superficial interactions with U87 cells that diminished over
time. These interactions were presented by individual micro-
glial cells, which extended and retracted their protrusions to
make surface contacts with the U87 cells. The differences in
microglial responses toward U87 cells and U251 cells high-
light intrinsic differences between these cell types. U251
cells are mutant for the tumor suppressor p53 and show high
levels of expression for GFAP, vimentin, and S100b, for
example.51 In contrast, U87 cells express wild-type tumor
suppressor p53 and lack GFAP or S100b expression.51 Fur-
thermore, U251 cells have been shown to express high levels
of CCL2, which stimulates microglial responses.14 The low
levels of CCL2 in U87 cells might be one of the reasons for
the lower number of interactions with microglia cells ob-
served in this study.
Our new model will facilitate new studies to reveal if mi-
croglia respond differently depending on glioblastoma subtype.
Basedon their gene expression, glioblastomas are classified into
the Proneural, Neural, Mesenchymal, or Classical subtype.61
Interestingly, differential expression levels of immune genes
have been detected between these glioblastoma subtypes.62
Thus, it is tempting to speculate that microglia recruitment and
activation will vary depending on the molecular glioblastoma
subtype.
Zebrafish microglia promote survival and invasiveness
of human glioblastoma cells
U87 and U251 cells showed differences in growth and in-
vasiveness upon transplantation into the zebrafish tectum.These
differences are in line with differences in their in vitro growth
rates and differences in invasiveness upon transplantation in
rodent models.53 When investigating how zebrafish microglia
activity affected these attributes, U87 and U251 glioblastoma
cells were clearly influenced by microglia. This was demon-
strated by the significant decrease in survival and invasiveness
of U87 cells in the irf8-/- zebrafish. In addition, U251 cell sur-
vival was also significantly decreased in the irf8-/- zebrafish.
Furthermore, treatment with the CSF-1R inhibitor BLZ945 re-
sulted in decreased U87 cell growth as previously observed in a
mouse proneural GBM model.26
In summary, these experiments show that zebrafish mi-
croglia develop a protumoral activity and promote the growth
of human glioblastoma cells. This highlights the suitability of
the larval zebrafish model to investigate the role of microglia
during brain tumor growth.
Conclusion
Finally, the fact thatmicroglia respond differently depending
on the glioma cell type could be very important when devel-
oping novel immunotherapeutics to target gliomas. Im-
munotherapeutics that specifically target microglia interactions
maywork on certain subtypes of gliomas, but the samedesirable
effect may not be achieved on others. The zebrafish xenograft
assay presented in this study will become a powerful tool in
cancer research to understand microglia–glioma interactions in
detail in vivo. Due to advances in vertebrate animal screening
technologies, zebrafish larvae can be screened and imaged
automatically in 96-well plate format.63 Thus, based on our
xenograft live imagingmodel, drug screening can be performed
on a medium to high throughput level to identify drugs that
impair the protumoral functions of microglia within gliomas.
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